Total Payments
$9,230
2024 Payments
$1,828
Companies
41
Transactions
569
Medicare Patients
3,223
Medicare Billing
$381,586
Payment Breakdown by Category
Food & Beverage$9,202 (99.7%)
Education$27.39 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,202 | 567 | 99.7% |
| Education | $27.39 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,519 | 242 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $885.02 | 48 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $766.18 | 41 | $0 (2024) |
| Janssen Biotech, Inc. | $739.18 | 45 | $0 (2024) |
| Gilead Sciences, Inc. | $558.90 | 27 | $0 (2024) |
| PFIZER INC. | $439.52 | 26 | $0 (2024) |
| GENZYME CORPORATION | $175.08 | 14 | $0 (2024) |
| Merck Sharp & Dohme LLC | $168.37 | 10 | $0 (2022) |
| ViiV Healthcare Company | $164.76 | 16 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $159.90 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,828 | 131 | ABBVIE INC. ($789.34) |
| 2023 | $1,289 | 81 | ABBVIE INC. ($478.33) |
| 2022 | $1,536 | 81 | ABBVIE INC. ($830.32) |
| 2021 | $938.71 | 51 | AbbVie Inc. ($529.09) |
| 2020 | $469.37 | 27 | AbbVie Inc. ($156.06) |
| 2019 | $878.62 | 54 | Takeda Pharmaceuticals U.S.A., Inc. ($201.58) |
| 2018 | $1,203 | 69 | AbbVie, Inc. ($226.05) |
| 2017 | $1,087 | 75 | AbbVie, Inc. ($335.61) |
All Payment Transactions
569 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.87 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: LIVER DISEASE | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.35 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | La Jolla Pharmaceutical Company | XACDURO (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/26/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $5.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: LIVER DISEASE | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.36 | General |
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 619 | 693 | $306,633 | $70,717 |
| 2022 | 16 | 908 | 1,089 | $442,680 | $108,618 |
| 2021 | 16 | 936 | 1,125 | $449,802 | $113,912 |
| 2020 | 13 | 760 | 941 | $345,338 | $88,340 |
Total Patients
3,223
Total Services
3,848
Medicare Billing
$381,586
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 142 | 142 | $106,500 | $18,089 | 17.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 54 | 54 | $33,696 | $9,081 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 108 | $21,276 | $8,994 | 42.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 108 | 146 | $19,418 | $8,884 | 45.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 38 | 38 | $33,782 | $7,342 | 21.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 71 | 72 | $35,640 | $5,297 | 14.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 19 | 19 | $11,856 | $3,228 | 27.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $11,856 | $2,580 | 21.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 36 | 36 | $15,120 | $2,575 | 17.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 18 | 22 | $11,066 | $1,977 | 17.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 25 | $3,375 | $1,494 | 44.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $3,048 | $1,177 | 38.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 161 | 161 | $120,750 | $21,439 | 17.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 74 | 74 | $46,176 | $12,903 | 27.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 80 | 80 | $29,920 | $11,608 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 130 | $25,610 | $10,813 | 42.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 100 | 192 | $25,920 | $10,175 | 39.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 117 | 164 | $21,812 | $9,709 | 44.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 34 | 34 | $30,226 | $6,278 | 20.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 74 | 74 | $36,630 | $5,519 | 15.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 53 | 53 | $22,260 | $4,087 | 18.4% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2022 | 11 | 11 | $14,223 | $3,864 | 27.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 20 | 20 | $12,480 | $3,484 | 27.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 24 | 24 | $14,976 | $3,346 | 22.3% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 21 | 29 | $14,587 | $2,804 | 19.2% |
About Dr. Thomas Lewis, MD
Dr. Thomas Lewis, MD is a Gastroenterology healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760478192.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Lewis, MD has received a total of $9,230 in payments from pharmaceutical and medical device companies, with $1,828 received in 2024. These payments were reported across 569 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($9,202).
As a Medicare-enrolled provider, Lewis has provided services to 3,223 Medicare beneficiaries, totaling 3,848 services with total Medicare billing of $381,586. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Nashville, TN
- Active Since 09/21/2005
- Last Updated 01/26/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1760478192
Products in Payments
- RINVOQ (Biological) $1,074
- HUMIRA (Biological) $738.84
- XIFAXAN (Drug) $623.18
- Humira (Biological) $450.08
- STELARA (Biological) $439.25
- Entyvio (Biological) $405.90
- XELJANZ (Drug) $390.76
- CREON (Drug) $376.62
- ENTYVIO (Biological) $334.98
- SKYRIZI (Biological) $304.30
- LINZESS (Drug) $259.32
- TRULANCE (Drug) $220.37
- REMICADE (Biological) $199.48
- ZENPEP (Drug) $173.07
- ESOPHYX (Device) $146.49
- MAVYRET (Drug) $142.94
- Creon (Drug) $137.10
- ZEPOSIA (Drug) $106.91
- ISENTRESS (Drug) $99.40
- Sucraid (Drug) $99.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Nashville
David Schwartz, Md, MD
Gastroenterology — Payments: $1.4M
Gastroenterology $1.4M
Dr. Dawn Borromeo Beaulieu, M.d, M.D
Gastroenterology — Payments: $442,218
Gastroenterology $442,218
Sara Horst, M.d, M.D
Gastroenterology — Payments: $211,441
Gastroenterology $211,441
Michael Vaezi, Md, Phd, MD, PHD
Gastroenterology — Payments: $139,482
Gastroenterology $139,482
Howard Mertz, M.d, M.D
Gastroenterology — Payments: $27,645
Gastroenterology $27,645
Ronald Pruitt, M.d, M.D
Gastroenterology — Payments: $18,331
Gastroenterology $18,331